2017
DOI: 10.1080/10717544.2017.1373167
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced tumor targeting effects of a novel paclitaxel-loaded polymer: PEG–PCCL-modified magnetic iron oxide nanoparticles

Abstract: PEG-PCCL-MNP is a potential candidate of biocompatible and tumor-specific targeting drug vehicle for hydrophobic drugs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 24 publications
(27 reference statements)
0
10
0
1
Order By: Relevance
“…Current investigations have also synthesized IONPs employing different shells with anticancer agents conventionally administered, such as β-cyclodextrin [ 135 ], carmustine [ 136 ], cetuximab [ 137 , 138 , 139 ], cytarabine [ 140 ], daunomycin [ 141 ], docetaxel [ 142 , 143 ], epirubicin [ 144 ], 5-fluorouracil [ 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 ], gemcitabine [ 22 , 154 , 155 , 156 , 157 , 158 ], methotrexate [ 159 , 160 , 161 ], mitoxantrone [ 162 , 163 , 164 , 165 ] and paclitaxel [ 27 , 104 , 166 , 167 , 168 , 169 , 170 , 171 , 172 ]. It is noteworthy, however, that these nanosystems demonstrate magnetic properties only in the presence of external magnetic fields to prevent agglomerations of nanoparticles [ 111 ] and to allow a satisfactory performance in the target sites.…”
Section: Drugs Bound To Ionpsmentioning
confidence: 99%
“…Current investigations have also synthesized IONPs employing different shells with anticancer agents conventionally administered, such as β-cyclodextrin [ 135 ], carmustine [ 136 ], cetuximab [ 137 , 138 , 139 ], cytarabine [ 140 ], daunomycin [ 141 ], docetaxel [ 142 , 143 ], epirubicin [ 144 ], 5-fluorouracil [ 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 ], gemcitabine [ 22 , 154 , 155 , 156 , 157 , 158 ], methotrexate [ 159 , 160 , 161 ], mitoxantrone [ 162 , 163 , 164 , 165 ] and paclitaxel [ 27 , 104 , 166 , 167 , 168 , 169 , 170 , 171 , 172 ]. It is noteworthy, however, that these nanosystems demonstrate magnetic properties only in the presence of external magnetic fields to prevent agglomerations of nanoparticles [ 111 ] and to allow a satisfactory performance in the target sites.…”
Section: Drugs Bound To Ionpsmentioning
confidence: 99%
“…En el caso de la terapia de hipotermia del cáncer, las nanopartículas con altos niveles de magnetismo han mostrado un excelente comportamiento en la producción de calor en las regiones del tejido canceroso y pueden localizarse en la zona del tumor mediante la manipulación de un campo magnético. Luego, las nanopartículas son calentadas aplicando un campo magnético alterno y el calor concentrado en el sitio canceroso causa la muerte de las células cancerosas y puede ser considerado como un método eficiente en tratamiento de tumores [28], [29]. Asimismo, se demostró que nanopartículas de óxido de hierro inhiben el crecimiento de células de cáncer de pulmón de células pequeñas (CPCP) previniendo la formación de metástasis hepáticas [30].…”
Section: Nanopartículas En Aplicaciones Médicasunclassified
“…Based on their results, PEG-PCCL-MMNP is a potential biocompatible candidate for tumor-specific targeting drug vehicles for hydrophobic drugs. 161 Chatzipavlidis et al produced magnetic pH-sensitive microcontainers. Figure 11 presents the preparation process of the Fe 3 O 4 poly(N,N0-methylenebis(acrylamide)comathacrylic acid) (P(MBAAm-co-MAA)) microcontainers and the chemical structure of Dau by a four-step process: 1) the fabrication of citrate-modified MNPs using the coprecipitation technique, 2) encapsulation of MNPs in noncrosslinked poly(methacrylic acid) (PMAA) microspheres leads to a core/shell structure, 3) synthesis of a P(MBAAm-co-MAA) layer on the magnetic PMAA microsphere surface in order to synthesize a trilayer hybrid microsphere, and 4) the removal of the PMAA layer in ethanol and formation of a stable P(MBAAm-co-MAA) microcontainer with MNPs entrapped inside the formed cavity.…”
Section: Modification Of Io Nps For Ptx and Dau Deliverymentioning
confidence: 99%